Universite de Caen Normandie
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
May 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 25, 2027The maintenance fee for Reagents for Reversibly Protecting Biological Molecules (US 11,708,375) comes due Jan 25, 2027. Unpaid by Jul 26, 2027, it lapses early.
- 1 fee due Feb 28, 2027The maintenance fee for Novel Photoinitiators Made from Bifunctional Silane (US 11,739,105) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
- 1 fee due Mar 12, 2027The maintenance fee for Computer-Implemented Process on an Image of a Biological Sample (US 11,756,194) comes due Mar 12, 2027. Unpaid by Sep 13, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,072,077 | Novel Antibody Useful in Neurological or Neurodegenerative Disorders In force · High confidence | In force | High confidence | |
| US 11,135,319 | Compounds Useful as Imaging Agents of Hypoxia In force · High confidence | In force | High confidence | |
| US 11,446,626 | Process for the Preparation of a Suspension of Nanosized Synthetic Zeolite Materials, Suspensions of Nanosized Synthetic Zeolite Materials Obtained by Said Process and Their Uses in Therapy and Diagnosis In force · High confidence | In force | High confidence | |
| US 12,291,750 | PREDICTIVE AND PROGNOSTIC USE OF A miRNA FOR HIGH GRADE SEROUS OVARIAN CARCINOMA THERAPEUTIC CARE In force · High confidence | In force | High confidence | |
| US 11,708,375 | Reagents for Reversibly Protecting Biological Molecules In force · High confidence | In force | High confidence | |
| US 12,123,000 | Use of PI3KC2B Inhibitors for the Preservation of Vascular Endothelial Cell Barrier Integrity In force · High confidence | In force | High confidence | |
| US 11,739,105 | Novel Photoinitiators Made from Bifunctional Silane In force · High confidence | In force | High confidence | |
| US 11,756,194 | Computer-Implemented Process on an Image of a Biological Sample In force · High confidence | In force | High confidence | |
| US 11,606,857 | Method for Determining a Quality Factor of an Accelerating Cavity of a Particle Accelerator In force · High confidence | In force | High confidence | |
| US 12,070,452 | Compounds targeting HSP110 protein for cancer treatment In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 21: 2 patents in force now held by others · 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
12 pending · 9 abandoned · 3 no status recorded